Aethlon Medical Revenue
Medical Equipment Manufacturing • 
San Diego, California, United States • 21-50 Employees
Aethlon Medical revenue & valuation
| Annual revenue | $574,245 |
| Revenue per employee | $25,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Medical Equipment Manufacturing industry and current estimated revenues | $1,900,000 |
| Total funding | $21,600,000 |
Key Contacts at Aethlon Medical
Angela Rossetti
Member Board Of Directors
Jim Frakes
Ceo & Cfo
Alessio Bloesch
Director Of Clinical Education And Product Innovation
Steve Robinson
Ceo
Company overview
| Headquarters | 11555 Sorrento Valley Road, Suite 203, San Diego, CA 92121, US |
| Phone number | +16199410360 |
| Website | |
| NAICS | 3391 |
| SIC | 283 |
| Keywords | Sepsis, Medical Device, Infectious Disease, Cancer Therapy, Targeted Exosome Research, Chronic Traumatic Encephalopathy |
| Founded | 1999 |
| Employees | 21-50 |
| Socials |
Aethlon Medical Email Formats
Aethlon Medical uses 2 email formats. The most common is {first initial}{last name} (e.g., jdoe@aethlonmedical.com), used 80% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}{last name} | jdoe@aethlonmedical.com | 80% |
{first name}{last name} | johndoe@aethlonmedical.com | 20% |
About Aethlon Medical
Aethlon Medical is a medical therapeutic device company focused on developing the Hemopurifier®, a clinical stage immunotherapeutic device which is designed to combat cancer and life-threatening viral infections. In human studies, the Hemopurifier has demonstrated the removal of life-threatening viruses and harmful exosomes from blood utilizing its proprietary lectin-based technology. This action has potential applications in cancer, where exosomes may promote immune suppression and metastasis, and in life-threatening infectious diseases. The Hemopurifier is a U.S. Food and Drug Administration (FDA) designated Breakthrough Device indicated for the treatment of individuals with advanced or metastatic cancer who are either unresponsive to or intolerant of standard of care therapy, and with cancer types in which exosomes have been shown to participate in the development or severity of the disease. The Hemopurifier also holds an FDA Breakthrough Device designation and an open Investigational Device Exemption (IDE) application related to the treatment of life-threatening viruses that are not addressed with approved therapies.
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
Aethlon Medical has 14 employees across 5 departments.
Departments
Number of employees
Funding Data
Explore Aethlon Medical's funding history, including investment rounds, total capital raised, and key backers.
Aethlon Medical Tech Stack
Discover the technologies and tools that power Aethlon Medical's digital infrastructure, from frameworks to analytics platforms.
Web servers
PaaS
JavaScript libraries
Tag managers
Security
JavaScript libraries
Miscellaneous
Miscellaneous
UI frameworks
Analytics
Miscellaneous
Security
Australia
Germany
Singapore
Slovenia
Frequently asked questions
4.8
40,000 users
